Late embryogenesis abundant protein D-19 Antibody

What are Late Embryogenesis Abundant (LEA) proteins and specifically what is the D-19 group?

LEA proteins are expressed during late embryo maturation and the developmentally regulated period of dehydration at the end of seed development. The D-19 group, also known as Group 1 LEA proteins, represents one of the most conserved LEA protein families across plant species. These proteins are characterized by approximately 20% glycine residues and a high proportion of charged and hydroxylated amino acids. They contain a distinctive 20-amino acid conserved motif that may be tandemly repeated up to four times, believed to result from gene duplication followed by recombination or deletion events . Expression of LEA proteins is highly correlated with desiccation tolerance in anhydrobiotic animals, selected land plants, and bacteria .

How do Group 1 LEA proteins function during water stress conditions?

Group 1 LEA proteins appear to buffer water loss during embryo maturation. Research on Arabidopsis indicates that these proteins play a crucial role in normal seed development. When the ATEM6 protein (a Group 1 LEA) is absent, seeds display premature dehydration and maturation, particularly at the distal end of siliques . In vitro studies have demonstrated that LEA proteins can protect reporter enzymes from inactivation during conditions of low water availability. The protective mechanisms likely involve stabilizing proteins and cellular structures during desiccation stress .

How are antibodies against LEA D-19 proteins typically produced for research applications?

For producing high-quality LEA protein antibodies, recombinant protein expression systems are commonly employed. As demonstrated in research with rotifer LEA proteins, polyclonal antisera can be raised against recombinant LEA proteins and then affinity-purified against the same protein. Due to the high sequence similarity between related LEA proteins (such as ArLEA1A and ArLEA1B in bdelloid rotifers), these antibodies often recognize multiple LEA family members in immunoblotting experiments . Commercial antibodies are typically provided in lyophilized format and require reconstitution with sterile water before use .

What considerations should be made when selecting antibodies for different LEA protein groups?

When selecting antibodies for LEA protein research, consider:

• Group specificity: Ensure the antibody targets the specific LEA group of interest (e.g., Group 1/D-19 vs. Group 4)

• Species cross-reactivity: LEA proteins show varying degrees of conservation across species

• Recognition of post-translational modifications: Some LEA proteins may undergo modifications during stress responses

• Antibody format: Consider whether the research requires polyclonal or monoclonal antibodies

• Application compatibility: Verify the antibody is validated for your intended applications (Western blot, immunohistochemistry, etc.)

Polyclonal antibodies against LEA proteins often recognize multiple family members due to sequence similarity, which can be advantageous for studying the entire family but may require additional specificity testing when targeting individual proteins .

How can LEA D-19 antibodies be used to study protein expression patterns during development and stress?

Methodological approach:

• Tissue sampling timeline: Collect plant tissues at different developmental stages, particularly focusing on late embryogenesis and during various stress conditions

• Protein extraction protocol:

  • Homogenize tissue in appropriate buffer containing protease inhibitors

  • Perform differential centrifugation if subcellular fractionation is required

  • Determine protein concentration using Bradford or BCA assay

• Immunoblotting procedure:

  • Separate proteins via SDS-PAGE (note that LEA proteins often migrate higher than expected due to incomplete SDS binding)

  • Transfer to membrane and block with appropriate blocking agent

  • Incubate with primary LEA antibody (typically 1:1000 to 1:5000 dilution)

  • Apply species-appropriate secondary antibody

  • Develop using chemiluminescence or fluorescence detection

• Immunolocalization:

  • Fix tissues with paraformaldehyde

  • Process for sectioning or whole-mount staining

  • Apply primary LEA antibody followed by fluorescent secondary antibody

  • Counterstain nuclei with DAPI for reference

  • Image using confocal microscopy

When analyzing results, researchers should be aware that LEA proteins might undergo processing into smaller peptides, as indicated by additional bands at lower molecular weights .

What are the best approaches for studying LEA protein subcellular localization using immunostaining?

Based on research with bdelloid rotifer LEA proteins, the following approach is recommended:

• Sample preparation:

  • For whole organism studies: Fix intact specimens in 4% paraformaldehyde

  • For cell culture: Grow cells on coverslips and fix with 4% paraformaldehyde

• Immunostaining procedure:

  • Permeabilize with 0.1% Triton X-100

  • Block with 5% normal serum from the species of secondary antibody

  • Incubate with affinity-purified LEA antibody (1:100-1:500 dilution)

  • Apply fluorophore-conjugated secondary antibody

  • Counterstain nuclei with DAPI

• Imaging considerations:

  • Use confocal microscopy for precise subcellular localization

  • Capture Z-stacks to analyze distribution throughout the cell

  • Include co-localization markers for specific organelles when needed

In bdelloid rotifers, LEA proteins were found throughout the organism but notably absent from nuclei. The proteins were present in cytoplasmic spaces, particularly in areas with densely packed cells, with exceptions such as the vitellarium .

What methods can be used to verify antibody specificity for LEA D-19 proteins?

Recommended verification protocol:

• Recombinant protein controls:

  • Express and purify recombinant LEA proteins of interest

  • Run alongside tissue extracts in immunoblotting

  • Verify recognition of proteins at expected molecular weights

• Antibody validation experiments:

  • Pre-adsorption test: Pre-incubate antibody with purified antigen before immunostaining

  • Knockout/knockdown controls: Use tissues from knockout mutants or RNAi-treated samples

  • Cross-reactivity assessment: Test against related LEA protein family members

• Mass spectrometry confirmation:

  • Immunoprecipitate LEA proteins using the antibody

  • Subject precipitated proteins to mass spectrometry analysis

  • Verify identity through peptide matching against databases

For example, in rotifer research, antibodies raised against ArLEA1A recognized both ArLEA1A and ArLEA1B recombinant proteins, detecting bands at approximately the expected molecular weights in protein extracts .

How can antibodies be used to investigate LEA protein trafficking and secretion pathways?

LEA proteins can possess specific trafficking signals that dictate their cellular localization. For example, in bdelloid rotifers, ArLEA1A and ArLEA1B contain an N-terminal ER translocation signal and a C-terminal ATEL sequence (a variant of the KDEL ER-retention signal). Research suggests this combination regulates the distribution of these proteins within intracellular vesicular compartments and the extracellular space .

Methodological approach:

• Cellular fractionation:

  • Isolate subcellular compartments (ER, Golgi, secretory vesicles)

  • Perform Western blotting for LEA proteins in each fraction

  • Compare with markers for each compartment

• Live cell trafficking studies:

  • Create LEA-fluorescent protein fusions

  • Visualize trafficking in live cells under various stress conditions

  • Use compartment-specific dyes for co-localization

• Brefeldin A treatment:

  • Apply Brefeldin A to disrupt ER-Golgi trafficking

  • Analyze redistribution of LEA proteins

  • Compare localization patterns before and after treatment

• Secretion assays:

  • Collect culture media from cells expressing LEA proteins

  • Concentrate proteins and analyze by immunoblotting

  • Compare wild-type and mutated trafficking signal variants

In mammalian cell models, LEA proteins with the ATEL sequence showed limited retention in the ER, with progression to the Golgi and partial secretion into the extracellular medium, unlike the classical KDEL retention signal .

How can LEA D-19 protein antibodies be utilized in comparative stress physiology studies across species?

Research approach:

• Cross-species antibody validation:

  • Test antibody recognition across phylogenetically diverse species

  • Determine optimal antibody concentrations for each species

  • Create a cross-reactivity profile based on sequence conservation

• Stress response profiling:

  • Subject different species to standardized stress conditions

  • Collect tissues at defined stress intensities and durations

  • Quantify LEA protein expression using calibrated immunoblotting

  • Create comparative expression profiles

• Experimental design considerations:

  Species Type	Sample Collection Points	Stress Gradient	Control Conditions
  Desiccation-tolerant	Pre-stress, 75%, 50%, 25%, 10%, 5% water content	Progressive drying	Fully hydrated
  Desiccation-sensitive	Pre-stress, 75%, 50% water content (or until viability loss)	Progressive drying	Fully hydrated
  Model organisms with transgenic LEA expression	Pre-stress, early, mid, late stress	Progressive drying	Wild-type organisms

• Co-immunoprecipitation across species:

  • Use LEA antibodies to pull down interacting proteins

  • Identify conserved and species-specific interactions

  • Map interaction networks related to stress response mechanisms

This approach allows researchers to correlate LEA protein expression patterns with desiccation tolerance capabilities across different organisms, providing insights into convergent evolution of stress adaptation mechanisms .

What are the most effective methods for analyzing LEA protein conformational changes during desiccation using antibody-based approaches?

LEA proteins undergo significant conformational changes during desiccation, typically transitioning from intrinsically disordered states to more structured conformations like alpha-helices . To study these changes:

Methodological approaches:

• Conformation-specific antibodies:

  • Develop antibodies that specifically recognize either the disordered or structured conformations

  • Use these for immunolabeling to track conformational states in situ

  • Apply in different hydration states to map the transition

• FRET-based biosensors:

  • Create fusion constructs with LEA protein between fluorescent protein pairs

  • Monitor conformational changes via FRET efficiency changes

  • Combine with immunoprecipitation to verify native protein behavior

• Limited proteolysis with immunodetection:

  • Subject partially dehydrated samples to mild protease treatment

  • Use LEA antibodies to detect fragment patterns by Western blotting

  • Compare digestion patterns across hydration states

  • Correlate with structural predictions and circular dichroism data

• In vitro analysis of LEA protein mutants:

  • Generate mutations that disrupt predicted structural elements (e.g., proline substitutions in predicted alpha-helical regions)

  • Express and purify mutant proteins

  • Compare immunoreactivity and protective function during desiccation

  • Assess whether loss of conformational change correlates with loss of function

Research with LEA4-5 protein from Arabidopsis thaliana has shown that certain mutations that inhibit alpha-helix formation (such as proline insertions) can significantly impact protective function under specific conditions, suggesting that conformational changes are functionally important .

What strategies can address weak or non-specific signals when using LEA D-19 antibodies?

Problem-solving approach:

• For weak signals:

  • Increase antibody concentration incrementally (e.g., from 1:1000 to 1:500)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use signal enhancement systems (biotinylated secondary antibodies with streptavidin-HRP)

  • Optimize protein extraction to preserve LEA proteins (include protease inhibitors)

  • Consider membrane type (PVDF may retain more protein than nitrocellulose)

• For non-specific binding:

  • Increase blocking stringency (5% BSA or milk protein)

  • Add 0.1-0.3% Tween-20 in wash buffers

  • Pre-adsorb antibody with non-target tissue lysate

  • Use higher salt concentration in wash buffers (up to 500 mM NaCl)

  • Consider affinity purification of polyclonal antibodies

• For multiple bands or unexpected molecular weights:

  • Remember that LEA proteins often migrate higher than expected in SDS-PAGE due to incomplete SDS binding

  • Consider potential post-translational modifications

  • Evaluate for proteolytic processing (some LEA proteins may be cleaved into smaller fragments)

  • Compare with positive controls using recombinant proteins

• For high background in immunofluorescence:

  • Optimize fixation conditions (time, temperature, fixative composition)

  • Extend blocking time or increase blocking agent concentration

  • Reduce primary antibody concentration

  • Include 0.1% Triton X-100 in antibody diluent

  • Use centrifugal filtration to remove antibody aggregates

How can researchers optimize immunoprecipitation protocols for LEA D-19 proteins?

Optimized protocol:

• Sample preparation:

  • Extract proteins in mild, non-denaturing buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate)

  • Include protease and phosphatase inhibitors

  • Pre-clear lysate with protein A/G beads for 1 hour at 4°C

• Antibody binding:

  • Covalently couple LEA antibodies to beads to prevent antibody contamination in eluted samples

  • Incubate lysate with antibody-coupled beads overnight at 4°C with gentle rotation

  • Use 2-5 μg antibody per mg of total protein

• Washing optimization:

  • Perform 4-5 washes with decreasing salt concentration

  • Include detergent in early washes, remove in later washes

  • Monitor washing efficiency by measuring protein concentration in wash fractions

• Elution strategies:

  • For native elution: use excess antigenic peptide or competing peptide

  • For denaturing elution: use 0.1 M glycine pH 2.5-3.0 (neutralize immediately)

  • For mass spectrometry: elute directly in MS-compatible buffer

• Controls and validation:

  • Include isotype control antibody immunoprecipitation

  • Use LEA knockout/knockdown samples as negative controls

  • Verify precipitated proteins by both Western blotting and mass spectrometry

What are the critical considerations when using LEA antibodies for quantitative expression analysis?

For accurate quantitative analysis of LEA protein expression:

• Standardization requirements:

  • Include recombinant LEA protein standards at known concentrations

  • Create standard curves covering the expected concentration range

  • Use the same antibody lot for all experiments in a series

• Sample preparation consistency:

  • Standardize tissue collection (time of day, developmental stage)

  • Use identical extraction protocols and protein determination methods

  • Load equal total protein amounts and verify with housekeeping protein controls

• Signal quantification approach:

  • Use digital imaging systems with linear dynamic range

  • Avoid film exposure for quantitative work

  • Perform multiple technical replicates

  • Include exposure series to ensure signals are within linear range

• Data normalization strategies:

  Normalization Method	Advantages	Limitations
  Total protein load	Simple, direct	Requires consistent extraction efficiency
  Housekeeping proteins	Common practice	May vary under stress conditions
  Multiple reference proteins	Greater reliability	Requires more resources and analysis
  Spiked internal standards	Highest accuracy	More complex implementation

• Statistical analysis:

  • Apply appropriate statistical tests for experimental design

  • Consider biological variability between replicates

  • Use power analysis to determine adequate sample size

  • Account for technical variance in measurements

By following these guidelines, researchers can generate reproducible and reliable quantitative data on LEA protein expression patterns across different experimental conditions.